Cancer

A groundbreaking discovery from the University of Surrey has illuminated a promising new pathway in the fight against one of...

A groundbreaking study led by researchers at BGI Genomics’ Institute of Intelligent Medical Research (IIMR) in collaboration with Sweden’s Karolinska...

Lung cancer remains the foremost cause of cancer-related deaths worldwide, challenging researchers and clinicians alike with its complex heterogeneity. Among...

In the world of pediatric rare diseases, Rosai-Dorfman disease (RDD) stands out as a captivating enigma, primarily affecting children and...

In a groundbreaking study, researchers have turned their attention to the evaluation of placental and fetal brain development using magnetic...

In a groundbreaking study that delves into the complex world of breast cancer, researchers led by Królewska-Daszczyńska, P., Englisz, A.,...

In the realm of pediatric medicine, one of the pressing concerns in managing kidney-related disorders involves the accurate interpretation of...

In the realm of pediatric medicine, the use of contrast agents during imaging procedures has long been a standard practice....

In a groundbreaking study published in BMC Cancer, researchers have delved into the intricate relationship between physical activity levels, performance...

In the relentless quest to unravel the molecular intricacies of cancer, a groundbreaking study has recently revealed an unexpected culprit...

In a groundbreaking new study published in BMC Cancer, researchers have unveiled a pivotal role for the gene ADAMTS2 in...

In the evolving landscape of cancer treatment, a groundbreaking approach is rapidly gaining traction, promising to redefine the paradigm of...

A groundbreaking study published in BMC Cancer has uncovered a compelling link between increased skin autofluorescence (SAF) and the future...

The global landscape of academic research has witnessed a significant shift in recent years, particularly in the domain of retinoblastoma,...

In the evolving battlefield of oncology, the emergence of cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors has ignited a beacon...

A groundbreaking clinical trial has been launched to assess the safety and effectiveness of afatinib, a promising targeted therapy, in...

In recent years, the intersection between advanced immune profiling technologies and oncology treatment has emerged as one of the most...

Recent studies have explored the intricacies of lung cancer, a leading cause of cancer-related mortality worldwide. Among the various subtypes,...

PON2, a member of the paraoxonase family of enzymes, has been primarily noted for its antioxidant properties. However, its implications...

In the intricate battleground of cancer and the immune system, a pioneering approach developed by researchers at Purdue University is...